chr12-9072799-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000014.6(A2M):c.3829C>A(p.Gln1277Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000014.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
A2M | NM_000014.6 | c.3829C>A | p.Gln1277Lys | missense_variant | 30/36 | ENST00000318602.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
A2M | ENST00000318602.12 | c.3829C>A | p.Gln1277Lys | missense_variant | 30/36 | 1 | NM_000014.6 | P1 | |
A2M | ENST00000543436.2 | n.452-4987C>A | intron_variant, non_coding_transcript_variant | 5 | |||||
A2M | ENST00000545828.1 | n.349-78C>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249636Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135392
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727240
GnomAD4 genome AF: 0.000164 AC: 25AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.3829C>A (p.Q1277K) alteration is located in exon 30 (coding exon 30) of the A2M gene. This alteration results from a C to A substitution at nucleotide position 3829, causing the glutamine (Q) at amino acid position 1277 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at